TY  - JOUR
AU  - Rueda-Fernandez, Manuel
AU  - Melguizo-Rodriguez, Lucia
AU  - Costela-Ruiz, Victor J
AU  - Gonzalez-Acedo, Anabel
AU  - Ramos-Torrecillas, Javier
AU  - Illescas-Montes, Rebeca
PY  - 2022
DO  - 10.1016/j.drudis.2022.08.004
UR  - http://hdl.handle.net/10668/22156
T2  - Drug discovery today
AB  - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a new disease that has led to a worldwide pandemic, resulting in millions of deaths and a high economic burden. Here, we analyze the current status of preventive vaccines authorized by...
LA  - en
PB  - Elsevier Ltd. * Trends Journals
KW  - Humans
KW  - NVX-CoV2373 adjuvated lipid nanoparticle
KW  - ChAdOx1 nCoV-19
KW  - SARS-CoV-2
KW  - BNT162 Vaccine
KW  - Ad26COVS1
KW  - 2019-nCoV Vaccine mRNA-1273
KW  - Financial Stress
KW  - Pandemics
KW  - United States Food and Drug Administration
KW  - Vaccines, Synthetic
KW  - Iatrogenic Disease
KW  - Headache
KW  - Pain
KW  - Adenoviridae
TI  - The current status of COVID-19 vaccines. A scoping review.
TY  - research article
VL  - 27
ER  -